Genprex (GNPX) Return on Equity (2017 - 2025)
Genprex (GNPX) has 9 years of Return on Equity data on record, last reported at 15.11% in Q3 2025.
- For Q3 2025, Return on Equity fell 756.0% year-over-year to 15.11%; the TTM value through Sep 2025 reached 15.11%, down 756.0%, while the annual FY2024 figure was 4.67%, 259.0% down from the prior year.
- Return on Equity reached 15.11% in Q3 2025 per GNPX's latest filing, down from 6.57% in the prior quarter.
- Across five years, Return on Equity topped out at 0.39% in Q2 2021 and bottomed at 15.11% in Q3 2025.
- Average Return on Equity over 5 years is 3.69%, with a median of 1.95% recorded in 2023.
- Peak YoY movement for Return on Equity: skyrocketed 55bps in 2021, then crashed -972bps in 2024.
- A 5-year view of Return on Equity shows it stood at 0.48% in 2021, then plummeted by -100bps to 0.95% in 2022, then tumbled by -228bps to 3.13% in 2023, then tumbled by -311bps to 12.85% in 2024, then fell by -18bps to 15.11% in 2025.
- Per Business Quant database, its latest 3 readings for Return on Equity were 15.11% in Q3 2025, 6.57% in Q2 2025, and 6.96% in Q1 2025.